Today news
About the same in other media
FDA Moving to Authorize Pfizer-BioNTech Booster for 16-, 17-Year-Olds
Reading now: 853
wsj.comThe Food and Drug Administration could authorize Covid-19 boosters from Pfizer Inc. and BioNTech SE for use in 16- and 17-year olds as soon as next week as concerns rise over the possible spread of a new, possibly more transmissible variant, according to a person familiar with the planning.
The agency is planning to move rapidly to take action on a request by the companies to authorize boosters for 16- and-17 year olds, according to a person familiar with the matter. So far, only people 18 years
Read more on wsj.comAbout this in other media
Stocks making the biggest moves premarket: Chewy, Lululemon, Beyond Meat, Peloton & more cnbc.com /3 years ago
Stocks making the biggest moves after hours: Oracle, Chewy, Lululemon and more cnbc.com /3 years ago
Stocks making the biggest moves midday: CVS, Lucid, Southwest Airlines, Boeing, GameStop and more cnbc.com /3 years ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
